| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/14/2004 | WO2003083609A3 Systems, methods and computer program products for determining parameters for chemical synthesis |
| 10/14/2004 | WO2003079974A3 Integrin ligand |
| 10/14/2004 | WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 10/14/2004 | WO2003072700A3 Androgen receptor overexpressing skeletal myoblasts |
| 10/14/2004 | WO2003072065A3 Drug signatures |
| 10/14/2004 | WO2003064592A3 Inhibitors of autoinducer transporters |
| 10/14/2004 | WO2003058198A3 Human breast cancer biomarkers |
| 10/14/2004 | WO2003035841A3 Methods and systems for dynamic gene expression profiling |
| 10/14/2004 | WO2002055664A3 Modulating insulin receptor signaling |
| 10/14/2004 | WO2002030980A8 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 10/14/2004 | WO2001094377A3 Metalloprotease peptide substrates and methods |
| 10/14/2004 | US20040204920 Method and apparatus for the detection of the response of a sensing device |
| 10/14/2004 | US20040204915 Chemical and biological agent sensor array detectors |
| 10/14/2004 | US20040204881 Environmental monitoring system |
| 10/14/2004 | US20040204655 Breath alcohol measuring device with improved mouthpiece |
| 10/14/2004 | US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/14/2004 | US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 10/14/2004 | US20040204490 Contacting with neurotransmitter recognition site ligand in the presence and absence of a steroid-based molecule; chimeric isoform; use in therapy of neurological disorders including ischemic stroke, epilepsy and schizophrenia |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/14/2004 | US20040204388 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein |
| 10/14/2004 | US20040204387 administering to subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof; for treating or preventing condition of central or peripheral nervous system or systemic organ associated with a disorder in protein folding or aggregation, or amyloid formation |
| 10/14/2004 | US20040204364 Peptides for activation and inhibition of deltaPKC |
| 10/14/2004 | US20040204359 Methods and compositions in treating pain and painful disorders using 16386,15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 |
| 10/14/2004 | US20040204357 Modulator of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
| 10/14/2004 | US20040204355 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204338 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 10/14/2004 | US20040203239 Methods for fabricating sample separation apparatus including porous silicon columns |
| 10/14/2004 | US20040203170 Methods for identification and verification |
| 10/14/2004 | US20040203167 Methods for isolating constituents of a sample |
| 10/14/2004 | US20040203164 Using colorimetric analysis and matrix impregnated with a signal producing system to determine glucose concentration in blood |
| 10/14/2004 | US20040203163 Monitoring to preventing clot formation to achieve artificial surface patency, to bring about clot formation to achieve vascular recovery and relative to balancing hemeotstasis toward an anticoagulation bias |
| 10/14/2004 | US20040203161 Method for testing the degradation of polymeric materials |
| 10/14/2004 | US20040203160 Method and device for analyzing the CO2 contained in a drilling fluid |
| 10/14/2004 | US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis |
| 10/14/2004 | US20040203137 requires no wash steps and thus generates no liquid waste; can be readily adapted to antigen-antibody interactions over a wide kinetic range; solid phase synthesis |
| 10/14/2004 | US20040203131 diagnosis of transmissible spongiform encephalopathies (TSEs) especially in an immunoassay, as well as its use as an immunogen; genetic engineering |
| 10/14/2004 | US20040203128 Use of PP2A phosphatase modulators in the treatment of mental disorders |
| 10/14/2004 | US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents |
| 10/14/2004 | US20040203104 for drug screening enzyme inhibitors; genetic engineering; comprising subjecting the sample to a polymerase chain reaction, a northern hybridization assay or an in situ hybridization assay |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203089 Method and apparatus for preparing cells for microtome sectioning and archiving nucleic acids and proteins |
| 10/14/2004 | US20040203088 Method of monitoring biofouling in membrane separation systems |
| 10/14/2004 | US20040203087 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 10/14/2004 | US20040203086 high speed; for analyzing glucose-6-phosphate dehydrogenase, total serum cholesterol, beta-lactamase activity and peroxidase activity |
| 10/14/2004 | US20040203085 Method for parallel synthesis and transfer of molecules to a substrates |
| 10/14/2004 | US20040203084 protein antigens for producing neutralizing antibodies; biodrugs |
| 10/14/2004 | US20040203083 immunoassay |
| 10/14/2004 | US20040203082 Method of detecting and analyzing paclitaxel-mimetic compounds |
| 10/14/2004 | US20040203079 analyzing lipocalin-type prostaglandin D2 synthase (PGDS); immunoassay; for pain management during trauma, labor and delivery, and surgery |
| 10/14/2004 | US20040203077 Method and kit for quantitation of polypeptides |
| 10/14/2004 | US20040203076 comprises immunoglobulins (I2), outer membrane protein C (OmpC), anti-Saccharomyces cerevisiae antibodies (ASCA) |
| 10/14/2004 | US20040203075 which bind pancreatic beta cells (to secrete insulin) and encapsulate cells for transplantation/treatment of diabetes; solid phase synthesis; kits |
| 10/14/2004 | US20040203072 analyzing aggrecans as markers for predicting cartilage destruction (as with osteoarthritis and rheumatic arthritis); kits |
| 10/14/2004 | US20040203071 Biomolecular-based actuator |
| 10/14/2004 | US20040203070 Method and means for detecting alcohol consumption |
| 10/14/2004 | US20040203069 Using labeled annexins to diagnose and monitor cell death in cancer and cardiovascular patients |
| 10/14/2004 | US20040203068 System for detection of nitrosylated proteins |
| 10/14/2004 | US20040203067 Methods for cancer prognosis and screening antiproliferative agents |
| 10/14/2004 | US20040203066 Identifying modulator of progression elevated gene-3 (PEG-3) for use in treatment and prevention of antitumor/antiproliferative/antisense agents; peptide mimetic |
| 10/14/2004 | US20040203065 Novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 10/14/2004 | US20040203064 Using expressed sequence tags to correlate gene expression profiles with stress/disease phenotypes |
| 10/14/2004 | US20040203060 Identifying modulators which decrease expression of melanoma differentiation associated factor (MDA) in tumor cells and lessens multidrug resistance in tumor cells; antitumor agents |
| 10/14/2004 | US20040203054 Use of SLIM3 for binding to molecules |
| 10/14/2004 | US20040203051 Nucleotide sequences coding two or more tumor associated antigens for use in identify modulators of major histocompatibility complex; preventing infections |
| 10/14/2004 | US20040203049 Coresponding biopolymer information coded on magnetic strip with silicon chip linked biopolymers |
| 10/14/2004 | US20040203045 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 10/14/2004 | US20040203043 Using multipathway high throughput assays to determine most effective combinations of modulator for treatment of acne, dandruff, cavities, skin disorders and infections |
| 10/14/2004 | US20040203041 Using probablistic analysis of nucleic acid sequences to determine nucleotide sequence, parameters of exons, sequence insertion/deletion events and open reading frames; bioinformatics and genetic/physical mapping of genes |
| 10/14/2004 | US20040203038 Process for preparing novel cyanine dye labeling reagents |
| 10/14/2004 | US20040203029 Method for the specific fast detection of threadlike bacteria |
| 10/14/2004 | US20040203023 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 10/14/2004 | US20040203022 clinical screening, diagnosis, prognosis, therapy and prophylaxis, as well as for drug screening and drug development using solid phase synthesis; kits |
| 10/14/2004 | US20040203020 Self-replicating RNA molecule from hepatitis C virus |
| 10/14/2004 | US20040203019 Methods and compositions for transcription-based nucleic acid amplification |
| 10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
| 10/14/2004 | US20040203012 kit for detecting human kallikrein 11 (hK11); may be used as a biomarker before surgery or after relapse; genetic engineering |
| 10/14/2004 | US20040203011 Fusion genes associated with acute megakaryoblastoc leukemias |
| 10/14/2004 | US20040203009 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/14/2004 | US20040203007 Cross reactive arrays of three-way junction sensors for steroid determination |
| 10/14/2004 | US20040203002 Determination of protein-DNA specificity |
| 10/14/2004 | US20040203000 Cell-signaling assays |
| 10/14/2004 | US20040202998 Method of amplifying or detecting HIV-1 RNA |
| 10/14/2004 | US20040202996 comprises a primary screen of a sample for nucleic acids, followed by a secondary screen for molecular markers, such as proliferation and cell cycle control group protein markers; significantly reduces number of false positive results |
| 10/14/2004 | US20040202667 also use in the development of antimalarial drugs and antibodies directed against these Plasmodium proteins. |
| 10/14/2004 | US20040202662 Humanised antibodies |
| 10/14/2004 | US20040202661 a peptide or derivative capable of binding to the IL-2 beta chain or the monoclonal antibodies produced by H2-8 hybridoma; induces SHC phosphorylation or induces the SHC/MAPK pathway |
| 10/14/2004 | US20040202656 Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders |
| 10/14/2004 | US20040202652 Methods and compositions for control of bone formation via modulation of leptin activity |
| 10/14/2004 | US20040202647 T cell line specific for a nitrotyrosine-containing compound; antibody specific for a self-antigen comprising a tyrosine to nitrotyrosine conversion; prevention and treatment of autoimmune diseases, infectious diseases and cancer through the recognition of compounds containing nitrated tyrosine residues |
| 10/14/2004 | US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy |
| 10/14/2004 | US20040202612 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| 10/14/2004 | US20040202610 Method and apparatus including use of metalloporphyrins for subsequent optimization of radiosurgery and radiotherapy |
| 10/14/2004 | US20040202603 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils |
| 10/14/2004 | US20040202577 integrated sample handling and detection system; simultaneous preparation and performance of multiple assays of rapidly occurring, transient phenomena in individual wells of a test plate; imaging of assays with sensitivity and a high degree of accuracy continuously; data analysis and storage |
| 10/14/2004 | US20040201840 Method for evaluating uniformity of spots in arrays |